Biotech

Career and Jobs News

Biotech Career and Jobs Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 23.09.2022.

#BioSpace
#LifeScience
#Biotech
#COVID
#PresidentJoeBiden
#RemoteJobs
#Regeneron
#Pfizer
#VesaliusTherapeutics
#COVIDPandemic

@biospace shared
On Sep 20, 2022
President Joe Biden declared the COVID-19 pandemic over but recognized there is still an ongoing problem with viral infections. #PresidentJoeBiden #COVID #COVIDPandemic #LifeScience #BioSpace https://t.co/vDa9wYXbCK
Open
Biden Declares 'COVID-19 Pandemic Over' as Biopharma Reacts (Updated)

Biden Declares 'COVID-19 Pandemic Over' as Biopharma Reacts (Updated)

Pres. Joe Biden declared the COVID-19 pandemic over. Biopharma stocks react as vaccines and antivirals are still in development.

@biospace shared
On Sep 22, 2022
In a recent BioSpace poll, more than half of employers indicated they planned to continue recruiting employees remotely. Here are some of those jobs. #RemoteJobs #Pfizer #Regeneron #LifeScience #BioSpace https://t.co/CuoBaS901A
Open
Remote Work Opportunities Abound at Pfizer, GRAIL, Regeneron and More

Remote Work Opportunities Abound at Pfizer, GRAIL, Regeneron and More

In a recent BioSpace poll, more than half of employers indicated they planned to continue recruiting employees remotely. We highlight just some of those jobs here.

@biospace shared
On Sep 20, 2022
Six months after its official launch by Flagship Ventures, Massachusetts-based Vesalius Therapeutics is laying off 43% of its staff. With a current headcount of 67, the company is slashing 29 jobs. #FlagshipVentures #VesaliusTherapeutics #Biotech #BioSpace https://t.co/JeJLxB85ct
Open
Slow Start? Vesalius Axes 43% of Staff 6 Months After Launch

Slow Start? Vesalius Axes 43% of Staff 6 Months After Launch

Six months after its launch, Vesalius Therapeutics is laying off 43% of its staff. With a current staff of 67, the company is slashing 29 jobs.

@ThePharmaLetter shared
On Sep 22, 2022
Cloud hangs over @AllogeneTx after partner's abrupt exit https://t.co/W3pNLrD3Y7 https://t.co/CZSY85J4qA
Open
Cloud hangs over Allogene after partner's abrupt exit

Cloud hangs over Allogene after partner's abrupt exit

Investors are jittery after the sudden departure of French drugmaker Servier from a collaboration in oncology with San Francisco’s Allogene Therapeutics.

@ThePharmaLetter shared
On Sep 20, 2022
@ucbventures partner poached for top job at NeuVasQ https://t.co/BQ4qvQFxda https://t.co/L7UapYojRu
Open
UCB Ventures partner poached for top job at NeuVasQ

UCB Ventures partner poached for top job at NeuVasQ

Belgium’s NeuVasQ Biotechnologies, a Université Libre de Bruxelles (ULB) spin-off developing pharmaceuticals to restore blood-brain barrier function, has named

@NatureBiotech shared
On Sep 22, 2022
.@GenScript and @GladstoneInst-@UCSF Institute of Genomic Immunology collaborate on groundbreaking non-viral cell therapy #NBTintheNews https://t.co/ONjG2CkzAs
Open
GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreaking Non-Viral Cell Therapy Study

GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreaking Non-Viral Cell Therapy Study

/PRNewswire/ -- GenScript USA Inc., the world's leading life-science research tools and services provider, is collaborating with researchers at the...

@promega shared
On Sep 21, 2022
RT @travelphotomag: 2022 Promega Fall Art Showcase Features Work of 60 Midwest Photographers - https://t.co/HuHmyreA0Y
Open
2022 Promega Fall Art Showcase Features Work of 60 Midwest Photographers

2022 Promega Fall Art Showcase Features Work of 60 Midwest Photographers

The 2022 Promega Fall Art Showcase will host the 12th Biennial PhotoMidwest Festival juried exhibition featuring the work of 60 photographers.

@pharminews shared
On Sep 22, 2022
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea https://t.co/CdNg8AIzEc #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews https://t.co/sdduBfRBU5
Open
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea

MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea

MedPharm, a global provider of contract topical and transdermal formulation development and manufacturing services, is pleased to announce that it will support Swiss Biotech company, ...